Cyclin-dependent kinases (CDKs) are key regulators of cell-cycle progression and have long been recognized as attractive therapeutic targets in oncology. Inhibitors of CDK4 and CDK6 have transformed the treatment of patients with breast cancer, providing proof... ...

请注册登录后继续浏览